doi: 10.4103/1673-5374.153681.
Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration
Affiliations
- PMID: 25878580
- PMCID: PMC4396094
- DOI: 10.4103/1673-5374.153681
Item in Clipboard
Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration
Neural Regen Res.
2015 Mar.
No abstract available
Figures
Schematic diagram demonstrating the effects of glaucoma and traumatic optic neuropathy on the eye and the potential of mesenchymal stem cells as a therapy.
Similar articles
-
Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury.Invest Ophthalmol Vis Sci. 2013 Nov 15;54(12):7544-56. doi: 10.1167/iovs.13-13045. Invest Ophthalmol Vis Sci. 2013. PMID: 24150755
-
Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration.Exp Eye Res. 2019 Aug;185:107699. doi: 10.1016/j.exer.2019.107699. Epub 2019 Jun 13. Exp Eye Res. 2019. PMID: 31202832
-
Long-term neuronal survival, regeneration, and transient target reconnection after optic nerve crush and mesenchymal stem cell transplantation.Stem Cell Res Ther. 2019 Apr 17;10(1):121. doi: 10.1186/s13287-019-1226-9. Stem Cell Res Ther. 2019. PMID: 30995945 Free PMC article.
-
The use of mesenchymal stem cells for the treatment of progressive retinal diseases: a review.Regen Med. 2019 May;14(4):321-329. doi: 10.2217/rme-2019-0022. Epub 2019 Apr 12. Regen Med. 2019. PMID: 30977436 Review.
-
A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.Stem Cell Rev Rep. 2017 Oct;13(5):598-602. doi: 10.1007/s12015-017-9750-4. Stem Cell Rev Rep. 2017. PMID: 28643176 Free PMC article. Review.
Cited by
-
Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.Prog Retin Eye Res. 2017 May;58:89-114. doi: 10.1016/j.preteyeres.2017.02.001. Epub 2017 Feb 20. Prog Retin Eye Res. 2017. PMID: 28223208 Free PMC article. Review.
-
Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.Front Neurosci. 2017 Sep 5;11:494. doi: 10.3389/fnins.2017.00494. eCollection 2017. Front Neurosci. 2017. PMID: 28928631 Free PMC article. Review.
-
Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury.Front Neurol. 2017 Feb 20;8:28. doi: 10.3389/fneur.2017.00028. eCollection 2017. Front Neurol. 2017. PMID: 28265255 Free PMC article. Review.
-
Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION).Stem Cell Investig. 2017 Nov 23;4:94. doi: 10.21037/sci.2017.11.05. eCollection 2017. Stem Cell Investig. 2017. PMID: 29270420 Free PMC article.
-
Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.J Mol Biol Ther. 2019;1:44-55. J Mol Biol Ther. 2019. PMID: 34528026 Free PMC article.
References
-
- Berry M, Ahmed Z, Lorber B, Douglas M, Logan A. Regeneration of axons in the visual system. Restor Neurol Neurosci. 2008;26:147–174. - PubMed
-
- Johnson TV, Dekorver NW, Levasseur VA, Osborne A, Tassoni A, Lorber B, Heller JP, Villasmil R, Bull ND, Martin KR, Tomarev SI. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome. Brain. 2013;137:503–519. - PMC - PubMed
-
- Levkovitch-Verbin H, Sadan O, Vander S, Rosner M, Barhum Y, Melamed E, Offen D, Melamed S. Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci. 2010;51:6394–6400. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources